Jean-francois Korobelnik MD, FEBO

Dr. Jean-François Korobelnik, MD PhD is a Professor of Ophthalmology and head of the department of ophthalmology at Bordeaux University Hospital. He completed his medical training at University Paris VII in 1985, was awarded a Master of Science (Diplome d'Etudes Approfondies) in 1989, completed his fellowship at Hotel-Dieu of Paris, and has held the Professorship of Ophthalmology in Vitreoretinal Surgery at the University Hospital, Bordeaux since 1999.

He is head of the Ophthalmology Department since May 2013. He is also involved in various industrial trials (multicenter prospective protocols to evaluate new drugs): Vastarel (SERVIER), Anecortave acetate (ALCON), Lucentis (NOVARTIS), Macugen (PFIZER), Ozurdex (ALLERGAN), Arxxant (LILLY), Eylea (BAYER). He is the author or co-author of more than 160 papers. Professor Korobelnik is a member of several societies, including the Vastarel (SERVIER), Anecortave acetate (ALCON), Lucentis (NOVARTIS), Macugen (PFIZER), Ozurdex (ALLERGAN), Arxxant (LILLY), Eylea (BAYER). He is the author or co-author of more than 160 papers. Professor Korobelnik is a member of several societies, including the Vastarel (SERVIER), Anecortave acetate (ALCON), Lucentis (NOVARTIS), Macugen (PFIZER), Ozurdex (ALLERGAN), Arxxant (LILLY), Eylea (BAYER). He is the author or co-author of more than 160 papers. Professor Korobelnik is a member of several societies, including the French Society of Ophthalmology e ( SFO), the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), the American Society of Retina Specialists (ASRS), Euretina, the European Association for Vision and Eye Research (EVER) and the Club Jules Gonin, and regularly participates in expert advisory board meetings for pharmaceutical organizations. He has been President of the SFO from May 2013 to May 2015.